SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-20-004479
Filing Date
2020-05-06
Accepted
2020-05-06 17:23:31
Documents
75
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT txmd-10q_033120.htm   iXBRL 10-Q 897188
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 16174
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 16340
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 7851
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 7962
  Complete submission text file 0001387131-20-004479.txt   5292702

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT txmd-20200331.xsd EX-101.SCH 68365
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT txmd-20200331_cal.xml EX-101.CAL 62469
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT txmd-20200331_def.xml EX-101.DEF 195587
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT txmd-20200331_lab.xml EX-101.LAB 456487
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT txmd-20200331_pre.xml EX-101.PRE 309957
73 EXTRACTED XBRL INSTANCE DOCUMENT txmd-10q_033120_htm.xml XML 694659
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-00100 | Film No.: 20853706
SIC: 2834 Pharmaceutical Preparations